Johnson & Johnson has announced plans to team up with the US government to invest more than $1 billion in a new vaccine against COVID-19, aiming to begin clinical trials by September.

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical ...

The Wyandotte woman had worked at Blue Cross for 32 years and was denied a religious accommodation to the insurer's vaccine ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

With flu season underway and new, developing COVID-19 strains ... in the U.S., after Johnson & Johnson, which is no longer available. The Novavax vaccine is the only non-mRNA updated COVID ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Patrick Ruane encouraged his 26,000-strong audience to shoot those involved in the vaccine rollout and burn “Big Pharma’ to ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

The decision by the regional board will likely give ammunition to vaccine-sceptics and anti-vaxxers who pushed against the ...

FILE - A syringe lies next to vials of COVID-19 booster vaccines at an inoculation station in ... The Associated Press Health ...

Local health care providers and the Wyoming Department of Health are recommending that most people consider getting a ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...